GE HealthCare has expanded its collaboration with RadNet's DeepHealth subsidiary to enhance and extend global access to AI-powered breast cancer screening solutions. This initiative, building on a 2024 partnership, will broaden the international offering of DeepHealth's Breast Suite, including advanced applications like ProFound Pro and Safeguard Review, designed to improve early cancer detection and workflow efficiency. The collaboration aims to advance women's health through precision care and AI-enhanced mammography, as showcased at the SBI Annual Symposium.

Medtronic plc has completed its acquisition of CathWorks for $585 million, aiming to revolutionize the diagnosis and treatment of coronary artery disease. CathWorks' FFRangio® System, which uses AI and computational science for comprehensive physiological assessment without invasive wires, will be integrated into Medtronic's interventional cardiology portfolio. This acquisition is part of Medtronic’s strategy to strengthen its leadership in core franchises and leverage high-growth merger and acquisition opportunities.

Honeywell has agreed to sell its productivity solutions and services unit to industrial equipment maker Brady for $1.4 billion in an all-cash deal. This divestiture is part of Honeywell's strategy to streamline its businesses before splitting its operations into separate aerospace, automation, and advanced materials units. The transaction is expected to close in the second half of 2026, and Brady anticipates it will be double-digit accretive to its adjusted profit within the first year.

Marvell Technology (MRVL) saw significant gains in premarket trading after reports surfaced that it might collaborate with Google on developing future AI chips. This news, however, led to dips for existing Google partners Broadcom (AVGO) and Celestica (CLS), as well as for Google itself (GOOG, GOOGL), reflecting a potential shift in Google's AI chip development strategy.

Brady Corp. has agreed to acquire Honeywell International’s productivity solutions and services business for $1.4 billion in an all-cash transaction. The deal includes Honeywell’s hardware, software, and services for automated data collection and tracking in mobile computers, barcode scanners, and printing. Honeywell had been reviewing strategic alternatives for this division.

Micron Technology is positioned at the center of the AI boom due to its expertise in high-bandwidth memory (HBM). The article explores whether the surging demand for AI memory can translate into sustained profits for investors, considering the company's core business model, key markets, competitive landscape, and strategic initiatives. While analysts are largely positive about AI-driven demand as a multi-year catalyst, risks such as cyclical oversupply and geopolitical tensions remain.

Wealth Enhancement Trust Services Inc. has made a new investment of $981,000 in U.S. Bancorp, acquiring 18,376 shares during the fourth quarter. This comes as U.S. Bancorp exceeded Q1 earnings expectations, reporting an EPS of $1.18 and revenue of $7.29 billion, driven by strong net interest income and fee revenue. Analysts currently hold a "Moderate Buy" consensus rating for U.S. Bancorp, with a target price of $61.18.

Vista Finance LLC significantly reduced its stake in FS KKR Capital Corp. (NYSE:FSK) by 36.8% in Q4, selling 91,537 shares and leaving it with 157,481 shares valued at $2.33 million. The stock is the 10th largest holding for Vista Finance LLC, comprising 1.5% of its portfolio. This reduction comes amid analyst downgrades and trimmed price targets, with the company also announcing a special dividend after missing its quarterly EPS consensus.

Trinity Capital Inc. (Nasdaq: TRIN) has committed $50 million in growth capital to Cala Health, a bioelectronic medicine company. This capital will support the commercial expansion of Cala Health's FDA-cleared Cala kIQ System, a wearable device designed to manage hand tremors in patients with essential tremor and Parkinson's disease. The funding aims to accelerate product innovation and market presence for the at-home therapy.

Trinity Capital Inc. has committed $50 million in growth capital to Cala Health, a bioelectronic medicine company specializing in wearable neuromodulation therapies for tremors. This funding will support the commercial expansion of Cala Health's FDA-cleared Cala kIQ® System, a wearable device that helps manage hand tremors for individuals with essential tremor and Parkinson's disease. The partnership aims to accelerate the delivery of personalized therapy to improve patients' daily lives.